Chronic pancreatitis is a progressive, irreversible inflammatory disorder that carries a particularly heavy burden in the Medicare population: among adults aged 65 and older, 40-60% develop exocrine pancreatic insufficiency, 70-80% develop endocrine dysfunction including brittle diabetes with elevated hypoglycemia risk, and 25-50% demonstrate osteoporosis by bone density testing. Despite this complexity, only 50-60% of patients receive optimized pancreatic enzyme replacement therapy dosing, and inadequate pain control, undertreatment of diabetes, and delayed cancer screening remain important drivers of preventable complications and avoidable hospitalizations.
AAVBC's Chronic Pancreatitis Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 coding by etiology, diagnostic criteria, exocrine and endocrine insufficiency management, PERT dosing standards, diabetes classification and management, pain control frameworks, nutritional support, alcohol use disorder documentation, comorbidity screening, and MEAT documentation standards. Grounded in current AGA, ACG, and ADA guideline evidence, this guide supports consistent, individualized clinical decision-making, helping care teams manage chronic pancreatitis comprehensively, document disease complexity, and coordinate care with the continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of chronic pancreatitis — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Chronic pancreatitis is a progressive, irreversible inflammatory disorder that carries a particularly heavy burden in the Medicare population: among adults aged 65 and older, 40-60% develop exocrine pancreatic insufficiency, 70-80% develop endocrine dysfunction including brittle diabetes with elevated hypoglycemia risk, and 25-50% demonstrate osteoporosis by bone density testing. Despite this complexity, only 50-60% of patients receive optimized pancreatic enzyme replacement therapy dosing, and inadequate pain control, undertreatment of diabetes, and delayed cancer screening remain important drivers of preventable complications and avoidable hospitalizations.
AAVBC's Chronic Pancreatitis Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 coding by etiology, diagnostic criteria, exocrine and endocrine insufficiency management, PERT dosing standards, diabetes classification and management, pain control frameworks, nutritional support, alcohol use disorder documentation, comorbidity screening, and MEAT documentation standards. Grounded in current AGA, ACG, and ADA guideline evidence, this guide supports consistent, individualized clinical decision-making, helping care teams manage chronic pancreatitis comprehensively, document disease complexity, and coordinate care with the continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of chronic pancreatitis — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
